← Back to Search

F-choline PET Imaging for Cancer Detection (F-choline Trial)

Phase 3

Recruiting

Led By Daniel Juneau, MD

Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

F-choline Trial Summary

This trial will assess the potential of 18-F-fluorocholine (F-choline) as a diagnostic tool in cancer and other medical conditions. F-choline is not approved for clinical use, but offers advantages over the approved 11-C-choline (C-choline). Researchers will compare the two tracers in various conditions to see if F-choline provides useful and incremental clinical information.

Who is the study for?

This trial is for adults with conditions where F-choline PET imaging might help in diagnosis or treatment decisions. It's not for pregnant or breastfeeding women, kids under 18, or anyone allergic to F-choline.Check my eligibility

What is being tested?

The study tests the use of an intravenous injection of F-choline as a PET imaging agent for various medical conditions. The goal is to see if it provides better information than current methods and affects patient care.See study design

What are the potential side effects?

Potential side effects are not detailed but may include reactions related to the injection of F-choline. Safety assessments will be part of the secondary objectives.

F-choline Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adverse reaction to the F-choline injection

Diagnostic performance (sensitivity and specificity) of F-choline PET/CT

Secondary outcome measures

Change in management following F-choline PET/CT

F-choline Trial Design

1Treatment groups

Experimental Treatment

Group I: Main armExperimental Treatment1 Intervention

F-choline intravenous injection

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor

366 Previous Clinical Trials

129,137 Total Patients Enrolled

Daniel Juneau, MDPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)

2 Previous Clinical Trials

21,000 Total Patients Enrolled

Media Library

F-choline intravenous injection Clinical Trial Eligibility Overview. Trial Name: NCT04999215 — Phase 3

F-Choline Uptake Lesion Research Study Groups: Main arm

F-Choline Uptake Lesion Clinical Trial 2023: F-choline intravenous injection Highlights & Side Effects. Trial Name: NCT04999215 — Phase 3

F-choline intravenous injection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04999215 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has F-choline received regulatory approval for intravenous use?

"There is available clinical data that suggests F-choline intravenous injection is safe, thus it received a score of 3."

Answered by AI

What is the total amount of people that are a part of this experiment?

"At the moment, this trial is not searching for new patients. The listing was first posted on July 1st, 2022 and was most recently edited on July 26th, 2022. There are 1 and 9 other trials respectively that are currently recruiting patients with lesions that show F-choline uptake or who may need F-choline intravenous injection."

Answered by AI

Are we currently enrolling patients in this trial?

"Unfortunately, this study is no longer recruiting patients, as reflected on clinicaltrials.gov. This trial was initially posted on July 1st, 2022 and received its last update on July 26th, 2022. However, there are 10 other trials that are still recruiting patients."

Answered by AI

Are there any precedents for this type of F-choline intravenous injection?

"Right now, 9 different clinical trials are researching F-choline intravenous injection. 2 of those trials are in the final Phase 3. The majority of the research is being conducted in Montréal, Quebec, but there are 10 total locations running these trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications

2022. "Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04999215.